Companies / Oncolytics Biotech Inc

Oncolytics Biotech Inc

Nasdaq: ONCYCIK 1129928SAN DIEGO, CAoncolyticsbiotech.com

Financials

Revenue
Net income$-28.76M
Total debt
Cash$4.12M
Diluted EPS$-0.30
Shares outstanding127.5M

Ownership

127.5M shares outstanding · as of Aug 10, 2026
1.7%Insiders
Ownership
Insiders1.68%2,143,775
Institutions0.76%971,708
Public float97.56%124,395,022

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
0.44%566,991
Pisano WayneDirector
0.39%492,414
Look KirkChief Financial Officer
0.23%287,515
Heineman Thomas CharlesChief Medical Officer
0.22%282,818
Hagerman AllisonChief Technology Officer
0.09%115,059
Kelly JaredCEOChief Executive Officer · Director
0.09%114,050
0.09%109,851
0.06%78,128
Aromando AndrewChief Business Officer
0.04%55,100
0.03%41,849

Institutional holders 5

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Marshall Wace, LLP
13F manager
NewCommon Stock$730.9K+860K
859,831
0.67% of shares
low
Q2 2026
as of
LPL Financial LLC
13F manager
NewCommon Stock$76.3K+80K
80,316
0.06% of shares
low
Q2 2026
as of
The PNC Financial Services Group, Inc.
13F manager
NewCommon Stock$14.3K+15K
15,055
0.01% of shares
low
Q2 2026
as of
Victory Capital Management, Inc.
13F manager
NewCommon Stock$12.8K+14K
13,506
0.01% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
NewCommon Stock$2.9K+3K
3,000
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ONCYCommon StockEquity68237V103BBG000DVS826